Skip to main content
. 2020 Feb 7;28(1):3–11. doi: 10.3727/096504019X15509383469698

Figure 2.

Figure 2

The VASH2 expression in NSCLC cell lines. (A) RT-PCR was performed to measure the expression of VASH2 in NSCLC cell lines (A549 and H358) and the normal cell line BEAS-2B. (B) Western blot was performed to measure the expression of VASH2 in NSCLC cell lines (A549 and H358) and the normal cell line BEAS-2B. (C) MTT assay was performed to measure the inhibition rate in A549 and H358 cells after doxorubicin treatment (2, 4, 8, 16, or 32 μmol/L). (D) The half maximal inhibitory concentration (IC50) was calculated from (C). *p < 0.05.